Delivery Order SPE2DB22D1017-SPE2DB25FG1CD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,586.41 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, aligning with...
- The Defense Logistics Agency awarded a delivery order valued at $12,196.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, representing...
- The Defense Logistics Agency awarded a delivery order valued at $3,364.00 to AmerisourceBergen Drug Corp for Jardiance 10 mg tablets (90-count packages) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a delivery order valued at $23,355.68 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $29,359.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $5,508.34 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order was issued on July 14, 2025, with no set-aside designation, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a widely-used diabetes medication, consistent with...
- The Defense Logistics Agency awarded a delivery order valued at $68,604.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, aligning with the...
- The Defense Logistics Agency awarded a delivery order valued at $19,623.85 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a commonly prescribed medication for diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $4,001.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on June 2, 2025, with an ultimate completion date of June 3, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication commonly used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $10,287.08 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used to treat type 2 diabetes and is part of the...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG1CDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $19,965.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on April 25, 2025, with an ultimate completion date of April 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management, consistent with AmerisourceBergen's portfolio of pharmaceutical products supplied to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor under this comprehensive global contract, AmerisourceBergen supplies a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare entities including the Defense Health Agency and U.S. Coast Guard. The company's position as a critical pharmaceutical distributor enables it to fulfill both routine and specialized medical supply requirements across multiple therapeutic domains for the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 4/25/25 |